STOCK TITAN
  1. Home
  2. Sec-filings
  3. QNTM
  4. [SCHEDULE 13G/A] Quantum Biopharma Ltd. Class B Subordinate Voting Shares SEC Filing

[SCHEDULE 13G/A] Quantum Biopharma Ltd. Class B Subordinate Voting Shares SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock QNTM logo
Quantum BioPharma Ltd

NASDAQ:QNTM

QNTM Rankings

#7145 Ranked by Market Cap
N/A Ranked by Dividends

QNTM Latest News

Aug 8, 2025
Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
Aug 7, 2025
Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt
Aug 5, 2025
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
Aug 4, 2025
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
Jul 31, 2025
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

QNTM Latest SEC Filings

Aug 8, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Aug 7, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Aug 5, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Aug 4, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)
Jul 31, 2025
[6-K] Quantum Biopharma Ltd. Class B Subordinate Voting Shares Current Report (Foreign Issuer)

QNTM Stock Data

89.49M
2.54M
8.79%
23.8%
3.99%
Biotechnology
Healthcare
Link
Canada
Toronto